Elizabeth A. Killion

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 217 citations · Full text

Glp-1r Agonists, Anti-obesity Effects, Immunology +20

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism

Elizabeth A. Killion, Michelle Chen, James R. Falsey et al. · Nature Communications · 2020 · 129 citations · Full text

A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction

Elizabeth A. Killion, Andrew R. Reeves, Mahmoud A. El Azzouny et al. · Molecular Metabolism · 2018 · 125 citations · Full text

Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption

Thomas A. Bowman, Kayleigh R. O’Keeffe, Theresa D’Aquila et al. · Molecular Metabolism · 2016 · 98 citations · Full text

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys

Shu-Chen Lu, Michelle Chen, Larissa Atangan et al. · Cell Reports Medicine · 2021 · 80 citations · Full text